- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03538977
Hydrotherapy in Premature Infants With Bronchopulmonary Dysplasia
October 11, 2018 updated by: Vanessa Suziane Probst, Universidade Estadual de Londrina
Effects of Hydrotherapy in Premature Infants With Bronchopulmonary Dysplasia During Hospitalization: a Randomized Clinical Trial
Premature newborns (PTNB) often develop bronchopulmonary dysplasia (BPD) which can be related to an inability to maintain differences in tonus patterns (extensor and flexor) between the cervical muscles, upper and lower limbs.
Babies who develop BPD remain in the neonatal intensive care unit (NICU) for a prolonged period of time, undergoing a large number of painful procedures.
Exposure to pain in premature newborns (PTNB) is one of the most damaging factors in the extrauterine environment, also causing stress, which can also interfere with tonus pattern.
Therefore, the aim of this study is to evaluate the effects of hydrotherapy on muscular activity, pain, sleep and wakefulness, stress, physiological conditions and the need for oxygen in PTNB with BPD during hospitalization in the neonatal unit.
EXPECTED RESULTS: Hydrotherapy is expected to relieve pain, improve sleep quality and reduce oxygen therapy and ventilatory support in hospitalized PTNB babies with BPD.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
INTRODUTION:The development of medicine in recent years, especially in neonatology, has contributed to a considerable reduction in mortality rates,however, with the increase in diseases that contribute to morbidity and mortality, such as bronchopulmonary dysplasia (BPD).
Such condition is defined by the need for supplemental oxygen and/or ventilatory support for more than 28 days.One of the complications of BPD is the inability to maintain differences in tonus patterns(extensor and flexor) between the cervical muscles, upper and lower limbs, which can be assessed by surface electromyography (EMG).
Babies who develop BPD remain in the neonatal intensive care unit (NICU) for a prolonged period of time, undergoing a large number of painful procedures.Exposure to pain in premature newborns (PTNB) is one of the most damaging factors in the extrauterine environment, also causing stress, which can be measured by salivary cortisol.Studies with pain relief methods in these babies are needed, such as hydrotherapy.This approach has proven to be effective and safe in reducing the signs of pain and stress and to improve sleep quality in preterm infants in the NICU, besides improving physiological parameters, such as peripheral oxygen saturation.
OBJECTIVES: To evaluate the effects of hydrotherapy on muscular activity, pain, sleep and wakefulness, stress, physiological conditions and the need for oxygen in PTNB with BPD during hospitalization in the neonatal unit.
METHODOLOGY: PTNB with a diagnosis of BPD will be randomized into two groups: conventional physiotherapy (GP) and conventional physiotherapy plus hydrotherapy (GH).
The PTNB randomized to GH will be submitted to 11 hydrotherapy sessions.
The PTNB from both groups will be submitted to evaluation of heart rate (HR), peripheral oxygen saturation (SpO2), respiratory rate (RR), pain, respiratory distress, sleep state, and wakefulness.
The level of salivary cortisol and muscular activity (EMG) will also be evaluated.
EXPECTED RESULTS: Hydrotherapy is expected to relieve pain, improve sleep quality and reduce oxygen therapy and ventilatory support in hospitalized PTNB babies with BPD.
Study Type
Interventional
Enrollment (Anticipated)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Victoria Escobar, Pt
- Phone Number: 5543 991462230
- Email: escobar.vic@gmail.com
Study Contact Backup
- Name: Darllyana Soares, Pt
- Phone Number: 5543 998365921
- Email: darllyana@hotmail.com
Study Locations
-
-
Paraná
-
Londrina, Paraná, Brazil, 86038-350
- Recruiting
- University Hospital
-
Contact:
- Vanessa S Probst, PT, PhD
- Phone Number: +554333712490
- Email: vanessaprobst@gmail.com
-
Contact:
- Darllyana S Soares, PT
- Phone Number: +554333712490
- Email: darllyana@hotmail.com
-
Principal Investigator:
- Vanessa S Probst, PT, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 months to 7 months (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- PTNB with gestational age less than 36 weeks with a diagnosis of BPD
- Babies without heart disease
- absence of central venous access, skin lesions, surgical wound, drainage and insufficiency of the adrenal gland.
Exclusion Criteria:
- Those unable to perform hydrotherapy for three consecutive days due to severe respiratory effort evaluated by the Silverman Andersen Bulletin and hemodynamic instability.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Conventional physiotherapy (GP)
The sample will be evaluated once a day in the morning until they complete at least 11 intervention sessions of conventional physiotherapy in five moments: immediately before therapy, immediately after, 15, 30 and 60 minutes after the intervention.While they are in need of intensive care and hospitalized in the NICU, infants will receive conventional physiotherapy care three times a day.
After discharge to the intermediate care unit (ICU), patients will receive care only once a day.
Evaluations and interventions will be carried out five days a week (Monday to Friday), according to the logistics of the unit.
|
Conventional physiotherapy consists of manipulations of Thoracoabdominal Rebalancing, a registered technique which uses simultaneous passive stretching of inspiratory muscles and stimulation of the diaphragm.
The manipulation used to improve the dynamic diaphragm included the thoracic-abdominal and lower abdominal support maneuvers.
Back repositioning was used to minimize posteriorization of the ribs and costal kyphosis due to thoracic distortion.
|
Experimental: GP + hydrotherapy (GH)
The sample will be evaluated once a day in the morning until they complete at least 11 intervention sessions of hydrotherapy in five moments: immediately before therapy, immediately after, 15, 30 and 60 minutes after the intervention.
While they are in need of intensive care and hospitalized in the NICU, infants allocated to GH, hydrotherapy will be performed once a day, associated with two sessions of conventional physiotherapy.
After discharge to the intermediate care unit (ICU), patients will receive care only once a day, both conventional physiotherapy and hydrotherapy.
Evaluations and interventions will be carried out five days a week (Monday to Friday), according to the logistics of the unit.
|
A re-sterilizable stainless steel bucket with an upper diameter of 30 cm, a depth of 32 cm, with water at a temperature between 37 and 38º Celsius will be used.
The amount of water used will be sufficient to keep the baby submerged up to shoulder height.
The baby will be immersed in the heated water of the bucket and will be suspended by occipital support performed by the physiotherapist, who alternates lateral-lateral and anteroposterior movements with only static suspension.
The therapy will last from eight to ten minutes and will be discontinued if there is agitation, cyanosis, worsening respiratory distress or major evacuation.
If the baby is using any type of ventilatory support or oxygen therapy, the same will be maintained during the procedure of hydrotherapy.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Peripheral oxygen saturation
Time Frame: Change from baseline peripheral oxygen saturation at 15, 30 and 60 minutes
|
Peripheral oxygen saturation (%) will be measured using a pulse oximeter.
Pulse oximetry is a method used to estimate the percentage of oxygen bound to hemoglobin in the blood and this variable will be assessed using a multi-parameter monitor.
|
Change from baseline peripheral oxygen saturation at 15, 30 and 60 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain evaluation
Time Frame: Change from baseline Neonatal Infant Pain Scale score at 15, 30 and 60 minutes.
|
Evaluated by Neonatal Infant Pain Scale, scores ranging from 0 to 7.
|
Change from baseline Neonatal Infant Pain Scale score at 15, 30 and 60 minutes.
|
State of sleep and wakefulness
Time Frame: Change from baseline Brazelton neonatal behavioral assessment scale scores at 15, 30 and 60 minutes.
|
Neonatal behavioral assessed by Brazelton neonatal behavioral assessment scale, scores ranging from 1 to 6.
|
Change from baseline Brazelton neonatal behavioral assessment scale scores at 15, 30 and 60 minutes.
|
Breathing pattern
Time Frame: Change from baseline Silverman and Andersen bulletin scores at 15, 30 and 60 minutes.
|
Respiratory distress assessed by Silverman and Andersen bulletin, scores ranging from 0 to 2.
|
Change from baseline Silverman and Andersen bulletin scores at 15, 30 and 60 minutes.
|
Muscular activity
Time Frame: Change from baseline surface electromiography at 60 minutes.
|
Muscular activity of trapezius, serratus anterior and erector spinae assessed by surface electromiography (Root Mean Square [RMS] in Volts).
|
Change from baseline surface electromiography at 60 minutes.
|
Respiratory rate
Time Frame: Change from baseline respiratory rate at 15, 30 and 60 minutes.
|
Respiratory rate (number of respiratory cycles per minute) will be assessed by a physiotherapist for one minute.
|
Change from baseline respiratory rate at 15, 30 and 60 minutes.
|
Heart rate
Time Frame: Change from baseline heart rate at 15, 30 and 60 minutes.
|
Heart rate (number of heart beat per minute) will be assessed using a multi-parameter monitor.
|
Change from baseline heart rate at 15, 30 and 60 minutes.
|
Stress level
Time Frame: Change from baseline salivary cortisol at 30 minutes.
|
Salivary cortisol (salivary cortisol in µg/dL) will be collected by aspirating saliva from the oral cavity of the infant with a 1mL syringe and depositing the contents in an appropriate storage container.
|
Change from baseline salivary cortisol at 30 minutes.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Vanessa Probst, PhD, State University of Londrina
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 11, 2018
Primary Completion (Anticipated)
May 1, 2019
Study Completion (Anticipated)
December 1, 2019
Study Registration Dates
First Submitted
April 10, 2018
First Submitted That Met QC Criteria
May 24, 2018
First Posted (Actual)
May 29, 2018
Study Record Updates
Last Update Posted (Actual)
October 16, 2018
Last Update Submitted That Met QC Criteria
October 11, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UEL-PPG Reabilitação
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bronchopulmonary Dysplasia
-
Centre Hospitalier Intercommunal CreteilNot yet recruitingControls Born at Term | Premature With Dysplasia Bronchopulmonary | Premature Without Dysplasia Bronchopulmonary
-
Adel MohamedHealth Sciences Centre, Winnipeg, Manitoba; Mount Sinai Hospital, CanadaCompletedBronchopulmonary Dysplasia (BPD)Canada
-
Children's Hospital of PhiladelphiaCompleted
-
Cynthia McEvoyUniversity of Florida; University of California, San Francisco; Thrasher Research... and other collaboratorsCompletedBronchopulmonary Dysplasia (BPD)United States
-
Children's Hospital of Eastern OntarioThe Hospital for Sick Children; Hannover Medical School; MOUNT SINAI HOSPITAL; St... and other collaboratorsRecruitingLung Function | BPD - Bronchopulmonary DysplasiaCanada
-
Christoph HornikNational Heart, Lung, and Blood Institute (NHLBI); University of North Carolina...RecruitingBronchopulmonary Dysplasia of NewbornUnited States
-
Medipost Co Ltd.RecruitingSevere Bronchopulmonary DysplasiaKorea, Republic of
-
PediatrixPhoenix Children's Hospital; Banner HealthActive, not recruitingBPD - Bronchopulmonary DysplasiaUnited States
-
University of FloridaCompletedPreterm Infant | Barotrauma | BPD - Bronchopulmonary DysplasiaUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedBronchopulmonary Dysplasia; Retinopathy of PrematurityItaly
Clinical Trials on Conventional Physiotherapy
-
Istanbul Demiroglu Bilim UniversityCompletedMuscle Weakness | Rehabilitation | Intensive Care Unit SyndromeTurkey
-
University of SalamancaRecruiting
-
Pamukkale UniversityCompletedChronic Low-back PainTurkey
-
University of LahoreRecruitingHypotonic Cerebral PalsyPakistan
-
Eastern Mediterranean UniversityCompletedCervical SpondylosisCyprus
-
Bezmialem Vakif UniversityCompleted
-
Riphah International UniversityNot yet recruitingAdhesive CapsulitisPakistan
-
Istanbul Demiroglu Bilim UniversityCompletedIntensive Care Unit Acquired WeaknessTurkey
-
Universidade Cidade de Sao PauloUnknown
-
University of ValenciaAsociación Parkinson ValenciaEnrolling by invitation